Skip to main content
Article
Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model
Blood (2011)
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Nural N. Orgun, Fred Hutchinson Cancer Research Center
  • Mark D. Hylarides, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Donald K. Hamlin, University of Washington
  • D. Scott Wilbur, University of Washington
  • Yukang Lin, Fred Hutchinson Cancer Research Center
  • Amiee L. Kenoyer, Fred Hutchinson Cancer Research Center
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • William I. Bensinger, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Johnnie J. Orozco, Fred Hutchinson Cancer Research Center
  • Theodore A. Gooley, Fred Hutchinson Cancer Research Center
  • Brent L. Wood, Seattle Cancer Care Alliance
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
Publication Date
November 18, 2011
Citation Information
Damian J. Green, Nural N. Orgun, Mark D. Hylarides, John M. Pagel, et al.. "Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model" Blood Vol. 118 Iss. 21 (2011) p. 1842 - 1842
Available at: http://works.bepress.com/john-pagel/173/